Literature DB >> 12878723

Microarray analysis of evolution of RNA viruses: evidence of circulation of virulent highly divergent vaccine-derived polioviruses.

Elena Cherkasova1, Majid Laassri, Vladimir Chizhikov, Ekaterina Korotkova, Eugenia Dragunsky, Vadim I Agol, Konstantin Chumakov.   

Abstract

Two approaches based on hybridization of viral probes with oligonucleotide microarrays were developed for rapid analysis of genetic variations during microevolution of RNA viruses. Microarray analysis of viral recombination and microarray for resequencing and heterogeneity analysis were able to generate instant genetic maps of vaccine-derived polioviruses (VDPVs) and reveal the degree of their evolutionary divergence. Unlike conventional methods based on cDNA sequencing and restriction fragment length polymorphism, the microarray approaches are better suited for analysis of heterogeneous populations and mixtures of different strains. The microarray hybridization profile is very sensitive to the cumulative presence of small quantities of different mutations, including those that cannot be revealed by sequencing, making this approach useful for characterization of profiles of nucleotide sequence diversity in viral populations. By using these methods, we identified a type-3 VDPV isolated from a healthy person and missed by conventional methods of screening. The mutational profile of the polio strain was consistent with >1 yr of circulation in human population and was highly virulent in transgenic mice, confirming the ability of VDPV to persist in communities despite high levels of immunity. The proposed methods for fine genotyping of heterogeneous viral populations can also have utility for a variety of other applications in studies of genetic changes in viruses, bacteria, and genes of higher organisms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12878723      PMCID: PMC170930          DOI: 10.1073/pnas.1633511100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  RNA virus mutations and fitness for survival.

Authors:  E Domingo; J J Holland
Journal:  Annu Rev Microbiol       Date:  1997       Impact factor: 15.500

2.  Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine-associated polio cases.

Authors:  G Y Lipskaya; A R Muzychenko; O K Kutitova; S V Maslova; M Equestre; S G Drozdov; R P Bercoff; V I Agol
Journal:  J Med Virol       Date:  1991-12       Impact factor: 2.327

3.  Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control.

Authors:  G V Rezapkin; L P Norwood; R E Taffs; E M Dragunsky; I S Levenbook; K M Chumakov
Journal:  Virology       Date:  1995-08-20       Impact factor: 3.616

4.  PCR engineering of viral quasispecies: a new method to preserve and manipulate genetic diversity of RNA virus populations.

Authors:  K M Chumakov
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

5.  Genetic stability of Sabin 1 strain of poliovirus: implications for quality control of oral poliovirus vaccine.

Authors:  G V Rezapkin; W Alexander; E Dragunsky; M Parker; K Pomeroy; D M Asher; K M Chumakov
Journal:  Virology       Date:  1998-06-05       Impact factor: 3.616

Review 6.  Resequencing and mutational analysis using oligonucleotide microarrays.

Authors:  J G Hacia
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

7.  Genetic bottlenecks and population passages cause profound fitness differences in RNA viruses.

Authors:  D K Clarke; E A Duarte; A Moya; S F Elena; E Domingo; J Holland
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

8.  Microevolution of Sabin 1 strain in vitro and genetic stability of oral poliovirus vaccine.

Authors:  G V Rezapkin; K M Chumakov; Z Lu; Y Ran; E M Dragunsky; I S Levenbook
Journal:  Virology       Date:  1994-07       Impact factor: 3.616

9.  TgPVR21 mice for testing type-3 oral poliovirus vaccines: role of clinical observation and histological examination.

Authors:  E Dragunsky; Y Chernokhvostova; R Taffs; K Chumakov; D Gardner; D Asher; T Nomura; K Hioki; I Levenbook
Journal:  Vaccine       Date:  1997-12       Impact factor: 3.641

10.  Vaccine-associated cases of poliomyelitis over a 30 year period in East Germany.

Authors:  G Driesel; S Diedrich; U Kunkel; E Schreier
Journal:  Eur J Epidemiol       Date:  1995-12       Impact factor: 8.082

View more
  27 in total

1.  Multiplex PCR method for identifying recombinant vaccine-related polioviruses.

Authors:  David R Kilpatrick; Karen Ching; Jane Iber; Ray Campagnoli; Christopher J Freeman; Nada Mishrik; Hong-Mei Liu; Mark A Pallansch; Olen M Kew
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  Retrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the future.

Authors:  Ekaterina A Korotkova; Renee Park; Elena A Cherkasova; Galina Y Lipskaya; Konstantin M Chumakov; Esfir V Feldman; Olen M Kew; Vadim I Agol
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

3.  Massively parallel sequencing for monitoring genetic consistency and quality control of live viral vaccines.

Authors:  Alexander Neverov; Konstantin Chumakov
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

4.  Genetic determinants of cell type-specific poliovirus propagation in HEK 293 cells.

Authors:  Stephanie A Campbell; Jennifer Lin; Elena Y Dobrikova; Matthias Gromeier
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine.

Authors:  E A Cherkasova; M L Yakovenko; G V Rezapkin; E A Korotkova; O E Ivanova; T P Eremeeva; L I Krasnoproshina; N I Romanenkova; N R Rozaeva; L Sirota; V I Agol; K M Chumakov
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  Evolution of the Sabin vaccine into pathogenic derivatives without appreciable changes in antigenic properties: need for improvement of current poliovirus surveillance.

Authors:  Maria L Yakovenko; Ekaterina A Korotkova; Olga E Ivanova; Tatyana P Eremeeva; Elena Samoilovich; Iryna Uhova; Gene V Gavrilin; Vadim I Agol
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

7.  Development and validation of DNA microarray for genotyping group A rotavirus VP4 (P[4], P[6], P[8], P[9], and P[14]) and VP7 (G1 to G6, G8 to G10, and G12) genes.

Authors:  Shinjiro Honma; Vladimir Chizhikov; Norma Santos; Masatoshi Tatsumi; Maria do Carmo S T Timenetsky; Alexandre C Linhares; Joana D'Arc P Mascarenhas; Hiroshi Ushijima; George E Armah; Jon R Gentsch; Yasutaka Hoshino
Journal:  J Clin Microbiol       Date:  2007-06-13       Impact factor: 5.948

8.  Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia.

Authors:  Soile Blomqvist; Carita Savolainen; Pia Laine; Päivi Hirttiö; Elisa Lamminsalo; Eija Penttilä; Silver Jöks; Merja Roivainen; Tapani Hovi
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  Detection and genotyping of Entamoeba histolytica, Entamoeba dispar, Giardia lamblia, and Cryptosporidium parvum by oligonucleotide microarray.

Authors:  Zheng Wang; Gary J Vora; David A Stenger
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

10.  A microarray based approach for the identification of common foodborne viruses.

Authors:  Mobolanle Ayodeji; Michael Kulka; Scott A Jackson; Isha Patel; Mark Mammel; Thomas A Cebula; Biswendu B Goswami
Journal:  Open Virol J       Date:  2009-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.